​Innovative partnership yields at least $1M per year through 2027 for ACS mission.

On Sept. 16, the American Cancer Society and Janus Henderson, a global active asset manager, announced an innovative partnership to support cancer research, advocacy, and patient support.

Through this pioneering initiative, Janus Henderson will donate an amount equal to half of its management fees for all assets under management from Janus Henderson’s Government Money Market Fund to ACS. Janus Henderson has committed to donating a minimum of $1 million per year to ACS for the next three years through this innovative partnership to support the fight against cancer.

"Together with Janus Henderson, we are supporting cancer patients and families across the cancer continuum by partnering in this innovative fundraising method,” said CEO Dr. Karen Knudsen. “Their generous support will increase our ability to fund groundbreaking research, advocate for better access to care at the federal and local levels and provide direct patient support to help us end cancer as we know it, for everyone.”

Janus Henderson’s partnership with ACS is part of Janus Henderson’s Brighter Future Project. To learn more about this initiative, please visit Janus Henderson | American Cancer Society.

The American Cancer Society does not endorse any service or product. Shares of Janus Henderson Government Money Market Fund are not sponsored, endorsed, or promoted by the ACS, and the ACS is not an investment adviser or service provider to the Fund, Janus Investment Fund, or Janus Henderson.

Pictured above are, left to right, Janus Henderson Investors Head of Innovation Nick Cherney, ACS CEO Dr. Knudsen, and Janus Henderson Investors CEO Ali Dibadj.